Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Study of Safety and Efficacy of Leflunomide for Maintenance of Remission in IgG4 Related Disease

NCT02703194 is registered in ClinicalTrials.gov with Chinese PLA General Hospital as lead sponsor.

NCT NCT02703194
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02703194 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Study of Safety and Efficacy of Leflunomide for Maintenance of Remission in IgG4 Related Disease
Lead sponsor
Chinese PLA General Hospital
Phase
Phase 4
Overall status
Completed
Start date
March 31, 2016
Completion date
January 31, 2019
Enrollment
68 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

immunoglobulin g4 related sclerosing disease